Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Genetic | 2 | 2015 | 94 | 1.010 |
Why?
|
| Transcription Factors | 2 | 2015 | 180 | 0.940 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2017 | 24 | 0.660 |
Why?
|
| Histones | 2 | 2015 | 53 | 0.640 |
Why?
|
| DNA Polymerase II | 1 | 2018 | 4 | 0.630 |
Why?
|
| Epigenesis, Genetic | 2 | 2015 | 104 | 0.600 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 409 | 0.570 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 154 | 0.550 |
Why?
|
| Deoxyribonuclease I | 1 | 2015 | 2 | 0.530 |
Why?
|
| Chromatin | 1 | 2015 | 25 | 0.530 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 78 | 0.510 |
Why?
|
| Mutation | 4 | 2018 | 486 | 0.490 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 148 | 0.480 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2015 | 200 | 0.440 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 41 | 0.280 |
Why?
|
| Protein Binding | 2 | 2015 | 201 | 0.250 |
Why?
|
| Computational Biology | 2 | 2015 | 91 | 0.250 |
Why?
|
| Genome, Human | 2 | 2015 | 132 | 0.240 |
Why?
|
| Organ Specificity | 3 | 2019 | 80 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 261 | 0.200 |
Why?
|
| Multiple Myeloma | 1 | 2021 | 20 | 0.190 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 725 | 0.180 |
Why?
|
| Humans | 11 | 2021 | 31837 | 0.180 |
Why?
|
| Magnetic Field Therapy | 1 | 2019 | 17 | 0.170 |
Why?
|
| Calcium Channels, T-Type | 1 | 2019 | 29 | 0.170 |
Why?
|
| Myeloid Cells | 1 | 2019 | 39 | 0.160 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 61 | 0.160 |
Why?
|
| DNA Copy Number Variations | 1 | 2018 | 13 | 0.160 |
Why?
|
| Genital Neoplasms, Female | 1 | 2018 | 16 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 2 | 2015 | 208 | 0.150 |
Why?
|
| Down-Regulation | 1 | 2018 | 142 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 159 | 0.150 |
Why?
|
| Calcium | 1 | 2019 | 304 | 0.150 |
Why?
|
| Signal Transduction | 2 | 2019 | 687 | 0.140 |
Why?
|
| Prognosis | 2 | 2018 | 1498 | 0.140 |
Why?
|
| Survival Analysis | 1 | 2018 | 487 | 0.140 |
Why?
|
| Software | 1 | 2017 | 127 | 0.140 |
Why?
|
| Base Composition | 1 | 2015 | 10 | 0.130 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 21 | 0.130 |
Why?
|
| Binding Sites | 1 | 2015 | 130 | 0.130 |
Why?
|
| Transcription Initiation Site | 1 | 2015 | 10 | 0.130 |
Why?
|
| Cyclin D2 | 1 | 2015 | 7 | 0.130 |
Why?
|
| RNA, Untranslated | 1 | 2015 | 10 | 0.130 |
Why?
|
| Base Sequence | 1 | 2015 | 251 | 0.120 |
Why?
|
| Radiation Tolerance | 1 | 2015 | 24 | 0.120 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 216 | 0.120 |
Why?
|
| RNA | 1 | 2015 | 92 | 0.120 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2017 | 192 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 68 | 0.120 |
Why?
|
| Cell Line | 1 | 2015 | 434 | 0.120 |
Why?
|
| DNA Methylation | 1 | 2015 | 140 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 1 | 2015 | 130 | 0.110 |
Why?
|
| Algorithms | 1 | 2015 | 495 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 760 | 0.100 |
Why?
|
| Female | 3 | 2018 | 19861 | 0.090 |
Why?
|
| Male | 2 | 2018 | 19096 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 323 | 0.070 |
Why?
|
| Aged | 2 | 2017 | 10287 | 0.060 |
Why?
|
| Middle Aged | 2 | 2017 | 11823 | 0.060 |
Why?
|
| Mice | 2 | 2021 | 2474 | 0.060 |
Why?
|
| Animals | 3 | 2021 | 7452 | 0.050 |
Why?
|
| Adult | 1 | 2015 | 9327 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 104 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2019 | 48 | 0.040 |
Why?
|
| Radiometry | 1 | 2019 | 39 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 77 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 114 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 114 | 0.040 |
Why?
|
| Neoplastic Stem Cells | 1 | 2019 | 99 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2018 | 37 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 103 | 0.040 |
Why?
|
| Pathology, Molecular | 1 | 2017 | 16 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 29 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 135 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2017 | 79 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2017 | 161 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2017 | 508 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 1014 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2017 | 180 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 45 | 0.030 |
Why?
|
| Azacitidine | 1 | 2015 | 28 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2015 | 48 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 493 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 835 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2017 | 1169 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 3295 | 0.020 |
Why?
|
| Neoplasms | 1 | 2017 | 692 | 0.020 |
Why?
|
| African Americans | 1 | 2017 | 1428 | 0.020 |
Why?
|